Cybin Inc. Common Stock (HELP)

Fundamentals

Market cap

$499.59M

P/E (trailing)

—

P/E (forward)

—

EPS (trailing)

—

Dividend yield

—

Beta

—

Avg. volume

—

Cybin Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• HELP

  Cybin Inc. Common Stock

  $12.18

  ▼ 8.01%
  Market cap $499.59MP/E —
• ARVN

  Arvinas Inc. Common Stock

  $9.16

  ▼ 0.87%
  Market cap $520.04MP/E 62.96
  $6.97$14.51
• QTTB

  Q32 Bio Inc. Common Stock

  $15.01

  ▼ 7.06%
  Market cap $451.37MP/E 15.71
  $1.62$23.57
• CBIO

  Crescent Biopharma Inc. Common Stock

  $17.74

  ▼ 0.14%
  Market cap $552.33MP/E —
  $8.72$27.41
• SGMT

  Sagimet Biosciences Inc. Series A Common Stock

  $10.55

  ▼ 1.86%
  Market cap $441.53MP/E —
  $4.5$11.15
• PRTA

  Prothena Corporation plc Ordinary Shares

  $9.35

  ▲ 2.86%
  Market cap $436.10MP/E —
  $7.73$11.8
• MPLT

  MapLight Therapeutics Inc. Common Stock

  $12.64

  ▲ 0.80%
  Market cap $569.09MP/E —
  $9.1$40.43

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Helus Pharma: An Undervalued Psychedelic Platform Approaching A Major Catalyst
  SeekingAlpha · 8/21/2026
• TD Cowen Maintains Buy on Helus Pharma, Raises Price Target to $62
  Benzinga · 8/20/2026
• Helus Pharma Q1 EPS $(0.91) Beats $(1.07) Estimate
  Benzinga · 8/14/2026
• Airsculpt Technologies, Barrick Mining And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
  Benzinga · 8/10/2026
• Helus Pharma Appoints Michael Halstead CEO, Effective Immediately
  Benzinga · 8/3/2026

Institutional Ownership

March 31, 2026

Total shares held

24.75M

Total value held

$117.87M

Institutional holders

80